Our Mega Summit Goes LIVE at 5pm Today >> READ MORE
Here is the latest stock price and chart of CAROL INFO. For a sector overview, read our pharmaceuticals sector report.
Live BSE Quotes | Mar 9, 2012 (Close) | ||
---|---|---|---|
Price (Rs)162.00 | Open (Rs) 162.05 | High (Rs) 162.45 | Low (Rs) 162.00 |
% Change-0.03 | Volume 11,680 | Value (Rs) 1,892,700 | 52-Week H/L 247.95 / 130.65 |
Live NSE Quotes | Mar 9, 2012 (Close) | ||
---|---|---|---|
Price (Rs)162.00 | Open (Rs) 161.65 | High (Rs) 162.45 | Low (Rs) 161.65 |
% Change0.00 | Volume 13,938 | Value (Rs) 2,258,100 | 52-Week H/L 241.70 / 130.05 |
Change | |||||
---|---|---|---|---|---|
1 Day -0.03% | 1 Month 2.53% | 3 Months 10.58% | 1 Year 13.80% | 5 Years (CAGR)* 27.94% | 10 Years (CAGR)* 18.69% |
* Compound Annual Growth Rate
BSE Sensex | CNX Nifty |
![]() |
||
PERIOD |
What else is happening in the markets today? Dig in...
The last traded price of CAROL INFO was Rs 162.0 on the BSE, down 0.0% over the previous close. On the NSE, CAROL INFO last traded price was up 0.0% at Rs 162.0.
Asian share markets opened mostly on the back foot today following another tepid lead from Wall Street as traders grew increasingly worried about the impact of surging inflation.
It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.
Here's why Divi's Lab's stock fell over 10% in two days.
For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.
During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.
The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?
More Views on NewsWith India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.
Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.
Some sectors have corrected by 50%. Do they merit a look?
This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.
Prudent investors should consider dividend aristocrats to create passive, predictable, and growing income to rely on whether the market moves up or down in these uncertain times.
More